Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 300 Mcg (0.3 Mg), 90-count Bottles
Recall Summary Accord Healthcare is recalling Levothyroxine Sodium Tablets 300 mcg in 90-count bottles nationwide because the medication is subpotent, meaning it contains less active ingredient than it should. This affects patients in all 50 states who received this prescription thyroid medication.
- Recalling firm
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 300 mcg (0.3 mg), 90-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-458-15.
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-08-06
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/325110f6-3084-4ed5-881b-01e1d966484a